gemtuzumab ozogamicin

Ligand id: 6775

Name: gemtuzumab ozogamicin

Compound class Antibody
Ligand families/groups Immune checkpoint modulators
Approved drug? Yes (FDA (2000), EMA (2018))
International Nonproprietary Names
INN number INN
10315 gemtuzumab ozogamicin
CDP 771 | CMA 676 | hP67.6-calicheamicin | Mylotarg® | WAY-CMA 676
This drug is an antibody-drug conjugate (ADC) that targets delivery of the highly cytotoxic ozogamicin (a derivative of calicheamicin γ1) to CD33 +ve myeloid cells [1].
Database Links
Specialist databases
IMGT/mAb-DB 44
Other databases
GtoPdb PubChem SID 178103381
PubChem SID 178103381
Search PubMed clinical trials gemtuzumab ozogamicin
Search PubMed titles gemtuzumab ozogamicin
Search PubMed titles/abstracts gemtuzumab ozogamicin
Wikipedia Gemtuzumab_ozogamicin